Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INFLUENT: Baloxavir Marboxil for Hospitalized Influenza Patients
NCT06653569Phase 3Recruiting
- Start
- Dec 2024
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of baloxavir marboxil in influenza. Started Dec 2024; status: recruiting.
02
Drugs
baloxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on NCT06653569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06653569.